Company / Operating Income per Share
C4 Therapeutics, Inc. Operating Income per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.63
FY2025
5-year range
-$2.84 / -$1.63
FY2022-FY2025
Trend
+29.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2.84 to $-1.63 over the past 2 years.
Based on SEC 10-K filings.
-1.63 in FY2025.
Improved from $-2.84 to $-1.63 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 29.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.63 | +29.0% |
| FY2024 | -$2.30 | +19.0% |
| FY2023 | -$2.84 | -68.3% |
| FY2022 | -$1.69 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026